The gifts include $2 million from the Shanghai-based Larry & Celia Moh Foundation to establish the A. Linn Murphree Retinoblastoma Program Chair. Named for CHLA ophthalmologist A. Linn Murphree, who established the retinoblastoma program at CHLA more than thirty years ago, the chair will be held by Jonathan W. Kim, director of the retinoblastoma program and an associate professor of ophthalmology at the USC Eye Institute. Murphree, who also is a professor of ophthalmology at the Eye Institute, pledged an additional $2 million to endow the chair.
The Mohs' son and daughter-in-law, Michael and Peggy Moh, have a teenage daughter who has been treated since infancy at the Vision Center for retinoblastoma, a rare childhood retinal cancer.
"We are very grateful for the vital funding provided by the Moh family and by Dr. Murphree," said Thomas C. Lee, division head of the Vision Center and associate professor of ophthalmology at the USC Eye Institute. "Their generosity will enable Dr. Kim and his team to carry on the legacy established by Dr. Murphree to research and develop new treatment modalities to save the eyes and lives of children with retinoblastoma."